Literature DB >> 16328196

[The prevalence of osteoporosis and associated health care use in women 45 years and older in Germany. Results of the first German Telephone Health Survey 2003].

C Scheidt-Nave1, A Starker.   

Abstract

The prevalence of osteoporosis and associated factors were assessed among women 45 years and older as part of the first nationwide German Telephone Health Survey (GSTel03). A total of 14.2% of women reported that a doctor had ever diagnosed them with osteoporosis. Among these about, 15% also reported a physician-diagnosed fragility fracture, the fracture question was restricted to the subgroup of women with osteoporosis. Point estimates of overall osteoporosis prevalence increased significantly across 10-year age bands from 4% in the lowest to 30% in the highest age group. There was no significant association of osteoporosis with socioeconomic status or residence in former East vs West Germany; however, osteoporosis was significantly overrepresented among women with a migration background in comparison to women born in Germany (age-adjusted odds ratio: 1.68; 95% CI: 1.07-2.63). In age-adjusted logistic regression models, osteoporosis was significantly related to physician-diagnosed arthritis or rheumatoid arthritis, significant stature loss (>5 cm) compared to height at age 25 years, postmenopausal hormone therapy, lower ratings of subjective health as well as increased utilization of health care services. No significant association was observed with body mass index computed from self-reported height and weight. In conclusion, despite methodological limitations, these population-based, representative data support the observation that osteoporosis is a prevalent and serious health problem among older women and reflect the considerable variability with regard to diagnosis and management of this condition. Studies evaluating quality of care as well as monitoring of disease endpoints and risk factors based on representative samples of the population are needed.

Entities:  

Mesh:

Year:  2005        PMID: 16328196     DOI: 10.1007/s00103-005-1166-7

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  7 in total

Review 1.  [New techniques for the diagnosis of osteoporosis].

Authors:  A S Issever; T M Link
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635

2.  [Prevalence and management of osteoporosis in trauma surgery. Implementation of national guidelines during inpatient fracture treatment].

Authors:  F Haasters; W C Prall; M Himmler; H Polzer; M Schieker; W Mutschler
Journal:  Unfallchirurg       Date:  2015-02       Impact factor: 1.000

3.  Fracture Risk and Risk Factors for Osteoporosis.

Authors:  Christian Schürer; Henri Wallaschofski; Matthias Nauck; Henry Völzke; Hans-Christof Schober; Anke Hannemann
Journal:  Dtsch Arztebl Int       Date:  2015-05-25       Impact factor: 5.594

4.  Osteoporosis in psoriatic arthritis: is there any?

Authors:  Simeon Grazio; Selma Cvijetić; Tonko Vlak; Frane Grubišić; Valentina Matijević; Tomislav Nemčić; Marija Punda; Zvonko Kusić
Journal:  Wien Klin Wochenschr       Date:  2011-11-29       Impact factor: 1.704

5.  Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis.

Authors:  Peter Oelzner; Antje Schwabe; Gabriele Lehmann; Thorsten Eidner; Sybille Franke; Gunter Wolf; Gert Hein
Journal:  Rheumatol Int       Date:  2008-04-30       Impact factor: 2.631

6.  Austrian Osteoporosis Report: epidemiology, lifestyle factors, public health strategies.

Authors:  Thomas Dorner; Elisabeth Weichselbaum; Kitty Lawrence; K Viktoria Stein; Anita Rieder
Journal:  Wien Med Wochenschr       Date:  2009-05

7.  Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany.

Authors:  Marie-Therese Puth; Manuela Klaschik; Matthias Schmid; Klaus Weckbecker; Eva Münster
Journal:  BMC Musculoskelet Disord       Date:  2018-05-14       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.